Letter to the Editor

PCC
Letter to the Editor

September 14, 2017

Misophonia, characterized by increased sensitivity to sound, results in intense emotional and behavioral responses to triggering auditory stimuli. Jenny is a 16-year-old girl with misophonia and social anxiety who...
,
PCC
Letter to the Editor

September 14, 2017

A male patient with recurrent depression and ADHD reports urinary hesitancy after starting atomoxetine. Read on to find out more about this patient and why the addition of atomoxetine...
, ,
PCC
Letter to the Editor

September 7, 2017

Negative symptoms cause serious personal, social, and occupational functioning disability in schizophrenia patients. To date, the effect of bright light therapy on negative symptoms has been rarely studied, and...
, , , et al
PCC
Letter to the Editor

August 31, 2017

Framing effects have a significant influence on medical decision-making; these effects stem from heuristics that physicians commonly use to diagnose patients. The framing itself may be created by the...
, , , et al
PCC
Letter to the Editor

August 31, 2017

The impact of thyroid disease on psychiatric symptoms is well-known but barely understood. A rare condition attracting increasing scientific interest is steroid responsive encephalopathy associated with autoimmune thyroiditis. The...
,
JCP
Letter to the Editor

August 23, 2017

,
JCP
Letter to the Editor

August 23, 2017

Telogen effluvium resulting in excessive hair loss is a very unpleasant side effect of valproate treatment, most often occurring in the first months of treatment. This case report describes...
,
JCP
Letter to the Editor

August 23, 2017

, , , et al
JCP
Letter to the Editor

August 23, 2017

JCP
Letter to the Editor

August 23, 2017

,
PCC
Letter to the Editor

August 17, 2017

This young man who tried to quit smoking by using varenicline learned that smoking was the least of his problems. Find out when his symptoms started and how long...
PCC
Letter to the Editor

August 17, 2017

Review these 2 cases to see whether medicating patients with schizophrenia who are not complaining of short sleep duration provides benefit to the patient or caregiver. 
, ,
PCC
Letter to the Editor

August 10, 2017

Clozapine use can produce another side effect in some patients: elevated CPK. But when nothing else works and the patient finally shows response, should you risk a rechallenge even...
, , , et al
PCC
Letter to the Editor

August 3, 2017

Clinicians should be able to recognize and manage potential side effects of clozapine, including myocarditis. However, treatment guidelines do not currently recommend a monitoring protocol for clozapine-induced myocarditis. This...
,
PCC
Letter to the Editor

August 3, 2017

It took 6 years for this patient with pathological giddiness to trek through a morass of specialists and find the proper diagnosis of moria, a condition perhaps most commonly...
, , , et al
PCC
Letter to the Editor

July 27, 2017

How would you help the patient with schizophrenia who believes that suicide is the only way to save his family? What about when he tries to starve himself? Read...
, ,
PCC
Letter to the Editor

July 27, 2017

A patient nonadherent to oral medication is always a challenge. These clinicians wanted to move theirs to depot drug administration to ensure better compliance. Fortunately, they started with oral...
, , , et al
PCC
Letter to the Editor

July 20, 2017

Patients with alcohol use disorders have a higher rate of gambling disorder than patients without alcohol use disorders. Read this case report of a patient with concurrent alcohol use...
,
PCC
Letter to the Editor

July 20, 2017

When addressing changes in symptom severity in patients with psychiatric disorders, it is important to consider psychosocial stressors before jumping to pharmaceutical interventions. Here, read 2 cases presented to...
PCC
Letter to the Editor

July 6, 2017

Antipsychotic medications have been shown to have significant interactions at acetylcholine receptors that may exacerbate symptoms in patients with myasthenia gravis. Here, read the first documented case of the...
, ,
PCC
Letter to the Editor

June 29, 2017

Dystonic reactions have not been commonly described with the second-generation antipsychotic lurasidone. Here, read the case of a patient with schizophrenia who developed episodes of recurrent oculogyric crises with...
, , , et al
JCP
Letter to the Editor

June 28, 2017

PCC
Letter to the Editor

June 15, 2017

Clozapine is the only antipsychotic approved for treatment-resistant schizophrenia; however, its use is limited due to potentially life-threatening side effects. Here, read the first report of an association between...
, , , et al
PCC
Letter to the Editor

June 15, 2017

Ms A presented to a dermatology clinic and reported ecchymosis on her legs. She recently started taking fluoxetine for depression. Could fluoxetine be the culprit? Read this case report...
,

Celebrating
85 Years

Read the Journal of Clinical Psychiatry

Subscribe to read
more articles

Subscribe